insights_auto
Outlook: 63.3% bullish·3.3% bearish
Go to analysischevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
၁.၄၆ US$
arrow_downward
-၁.၀၂%(-၀.၀၁၅) 1D
၁.၄၁ US$
arrow_downward
-၃.၄၂% (-၀.၀၅၀)bedtimeAfter hours
Closed: နို ၁၂, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
၁.၄၄ US$
High
၁.၅၃ US$
Low
၁.၃၃ US$
Mkt. cap
၂၇.၂၅ ကုဋေ
Avg. vol.
၁.၉၁ ကုဋေ
Volume
၀.၀၀
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၆ US$
EPS
-၁.၁၇ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
Open
၁.၄၄ US$
High
၁.၅၃ US$
Low
၁.၃၃ US$
Mkt. cap
၂၇.၂၅ ကုဋေ
Avg. vol.
၁.၉၁ ကုဋေ
Volume
၀.၀၀
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၆ US$
EPS
-၁.၁၇ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
News stories
From web sources and news partners
News Corp
·
ပြီးခဲ့သည့် ၈ နာရီ
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
MarketWatch
·
ပြီးခဲ့သည့် ၈ နာရီ
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
GuruFocus
·
ပြီးခဲ့သည့် ၁၈ နာရီ
Inovio Pharmaceuticals Inc (INO) (Q3 2026) Earnings Call Highlig
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ ရက်
Inovio Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc